Clinical Trial

Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bone and Soft Tissue Tumors

Study acronym: ICG-BST
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Investigate the application protocol, feasibility, and efficacy of indocyanine green (ICG)-assisted near-infrared (NIR) fluorescence-guided resection in bone and soft tissue tumors. Assess the incidence of adverse events and evaluate the safety of the protocol.
Trial Details
NCT Number NCT06979115
Lead Sponsor Guangdong Provincial People's Hospital
Conditions Bone Neoplasms, Soft Tissue Neoplasms
Enrollment 40 participants
Start Date 2025-05-25
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-18